Targeting inflammation-induced Kasabach-Merritt phenomenon
Blood（2022）
摘要
In this issue of Blood, Ji et al(1) identified that up-front dual therapy sirolimus plus prednisolone induced faster resolution of life-threatening Kasabach-Merritt phenomenon (KMP) in children with kaposiform hemangioendothelioma (KHE) compared with sirolimus monotherapy.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要